AIM ImmunoTech Inc. (AIM) stock
AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.14+0.01 (+3.82%)
Close on Nov 17, 2026Market cap $4.14MP/E –Yield –
AIM ImmunoTech revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
AIM ImmunoTech's revenue for the twelve months ending Jun 30, 2026 was $95.00K, down 21.5% year over year. For fiscal 2025 it was $88.00K, down 48.2% from the year before. Over ten years it grew -4.0% a year on average. The highest annual figure on record is $437.00K in fiscal 2017.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $88.00K | -48.2% |
| FY2024 | Dec 31, 2024 | $170.00K | -15.8% |
| FY2023 | Dec 31, 2023 | $202.00K | +43.3% |
| FY2022 | Dec 31, 2022 | $141.00K | +4.4% |
| FY2021 | Dec 31, 2021 | $135.00K | -17.2% |
| FY2020 | Dec 31, 2020 | $163.00K | +16.4% |
| FY2019 | Dec 31, 2019 | $140.00K | -61.9% |
| FY2018 | Dec 31, 2018 | $367.00K | -16.0% |
| FY2017 | Dec 31, 2017 | $437.00K | +375.0% |
| FY2016 | Dec 31, 2016 | $92.00K | -30.8% |
| FY2015 | Dec 31, 2015 | $133.00K | -32.5% |
| FY2014 | Dec 31, 2014 | $197.00K | +31.3% |
| FY2013 | Dec 31, 2013 | $150.00K | -29.6% |
| FY2012 | Dec 31, 2012 | $213.00K | +32.3% |
| FY2011 | Dec 31, 2011 | $161.00K | +19.3% |
| FY2010 | Dec 31, 2010 | $135.00K | +21.6% |
| FY2009 | Dec 31, 2009 | $111.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $26.00K | +4.0% |
| Q1 FY2026 | Mar 31, 2026 | $22.00K | +37.5% |
| Q4 FY2025 | Dec 31, 2025 | $21.00K | -53.3% |
| Q3 FY2025 | Sep 30, 2025 | $26.00K | -25.7% |
| Q2 FY2025 | Jun 30, 2025 | $25.00K | -50.0% |
| Q1 FY2025 | Mar 31, 2025 | $16.00K | -60.0% |
| Q4 FY2024 | Dec 31, 2024 | $45.00K | -30.8% |
| Q3 FY2024 | Sep 30, 2024 | $35.00K | -23.9% |
| Q2 FY2024 | Jun 30, 2024 | $50.00K | -10.7% |
| Q1 FY2024 | Mar 31, 2024 | $40.00K | +90.5% |
| Q4 FY2023 | Dec 31, 2023 | $65.00K | +116.7% |
| Q3 FY2023 | Sep 30, 2023 | $46.00K | +39.4% |
| Q4 FY2022 | Dec 31, 2022 | $56.00K | +12.0% |
| Q3 FY2022 | Sep 30, 2022 | $21.00K | -36.4% |
| Q2 FY2022 | Jun 30, 2022 | $30.00K | +30.4% |
| Q1 FY2022 | Mar 31, 2022 | $33.00K | +17.9% |
| Q4 FY2021 | Dec 31, 2021 | $50.00K | +19.0% |
| Q3 FY2021 | Sep 30, 2021 | $33.00K | -8.3% |
| Q2 FY2021 | Jun 30, 2021 | $23.00K | -42.5% |
| Q1 FY2021 | Mar 31, 2021 | $28.00K | -37.8% |
| Q4 FY2020 | Dec 31, 2020 | $42.00K | -16.0% |
| Q3 FY2020 | Sep 30, 2020 | $36.00K | -41.0% |
| Q2 FY2020 | Jun 30, 2020 | $40.00K | +37.9% |
| Q1 FY2020 | Mar 31, 2020 | $45.00K | -81.3% |
| Q4 FY2019 | Dec 31, 2019 | $50.00K | +31.6% |
| Q3 FY2019 | Sep 30, 2019 | $61.00K | +84.8% |
| Q2 FY2019 | Jun 30, 2019 | $29.00K | -48.2% |
| Q4 FY2018 | Dec 31, 2018 | $240.00K | +380.0% |
| Q3 FY2018 | Sep 30, 2018 | $38.00K | -57.8% |
| Q2 FY2018 | Jun 30, 2018 | $33.00K | -84.5% |
| Q1 FY2018 | Mar 31, 2018 | $56.00K | -33.3% |
| Q4 FY2017 | Dec 31, 2017 | $50.00K | +212.5% |
| Q3 FY2017 | Sep 30, 2017 | $90.00K | +309.1% |
| Q2 FY2017 | Jun 30, 2017 | $213.00K | +1320.0% |
| Q1 FY2017 | Mar 31, 2017 | $84.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $16.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $22.00K | – |
| Q2 FY2016 | Jun 30, 2016 | $15.00K | – |
See a number that looks wrong?